- Medically Reviewed by: Mr Mfazo Hove, Consultant Ophthalmic Surgeon
- Author: Mr Mfazo Hove
- Published: June 3, 2026
- Last Updated: June 3, 2026
ZEISS EMEA Cataract & Corneal Refractive User Meeting - Istanbul, Türkiye - 5-7 June 2026
Blue Fin Vision® on the European stage: how a founding surgeon and a practice manager came to argue the same case, that modern cataract and refractive care is decided long before the patient reaches the clinic.
Focus Session D, ZEISS EMEA User Meeting, Istanbul: Mr Mfazo Hove (Moderator) and Dr Bukie Hove of Blue Fin Vision®, with Mr Sanjog Sandhu (VISIO Health, UK) and Dr Jascha Wendelstein (IROC, Switzerland).
At this year’s ZEISS EMEA Cataract & Corneal Refractive User Meeting in Istanbul, Focus Session D gathers clinicians and practice leaders from across Europe to examine how refractive and cataract practices are actually built in a digital-first era. Blue Fin Vision® is represented twice on the panel.
Mr Mfazo Hove, the practice’s founder and consultant ophthalmic surgeon, chairs the session and opens it. Dr Bukie Hove, the practice’s manager, presents alongside him. They share the platform with Mr Sanjog Sandhu of VISIO Health (United Kingdom) and Priv.-Doz. Dr Jascha Wendelstein of IROC (Switzerland), a deliberately international line-up that places UK practice innovation in direct conversation with European peers.
That an independent UK clinic should field both its clinical and its operational leadership on a European faculty is itself the argument. The two Blue Fin Vision® talks were written separately, but they answer one question from opposite ends of the same pathway: in modern private ophthalmology, how does a consultant-led practice earn, and keep, the patient in front of it?
Presentation One: Mr Mfazo Hove
The First Consultation Moved Online
Mr Hove’s talk names a shift most practices have felt but few have built around: the referral pathway has inverted. The route that once ran optometrist → referral → surgeon now begins with search engines, AI assistants and patient reviews. None of this displaces the optometrist, who remains a trusted clinical adviser and central to ongoing eye care; what has changed is the order in which information reaches the patient, not the value of the professional advice they receive. By the time a patient makes contact, a great deal of the decision has already been made.
The international evidence is consistent. Patients now routinely research their condition and their options online before a consultation, and most report that doing so improves rather than undermines the encounter.¹ Online ratings and reviews materially influence which clinician patients choose,² an effect documented even in the choice of surgeon for major operations.³ The first consultation, in other words, now happens before the clinic.
Mr Mfazo Hove’s opening presentation for Focus Session D.
Blue Fin Vision®’s response was to document, not to advertise. Its content did not begin as search-engine pages; every page began as a question asked repeatedly in clinic, glare and halos, monofocal versus trifocal lenses, dry eye after surgery, retinal detachment risk, enhancement pathways, and what happens when things go wrong. That depth does real clinical work: in cataract surgery specifically, providing structured pre-operative information has been shown in controlled study to lower patient anxiety substantially.⁴ The same depth, published openly, became discoverability.
The results followed from the philosophy rather than from any change of tactics: across a 16-month period the practice saw sustained, multi-fold growth in organic visibility. The figures below are a snapshot of that trajectory rather than a static claim:
374 → 3,989 | 38k → 535k | 14.3 → 7.5 | 100k |
|---|---|---|---|
CLICKS / DAY | IMPRESSIONS / DAY | AVG. SEARCH POSITION | CLICKS IN 28 DAYS |
Source: Google Search Console · January 2025 – May 2026
What converts is not volume but trust, and trust is the reduction of uncertainty: the same pathway for every patient, with every scan, letter and diagnostic shared, and complexity explained rather than smoothed away. That stance rests on measurable accountability. Blue Fin Vision® publishes its results through the Royal College of Ophthalmologists’ National Ophthalmology Database, the audit framework used to benchmark cataract surgery across the United Kingdom,⁵ reporting a posterior-capsule-rupture rate of approximately 0.2% against a national benchmark close to 0.8%.
“The internet did not replace the consultation. It moved the first consultation online.”
Mr Mfazo Hove, Founder & Consultant Ophthalmic Surgeon, Blue Fin Vision®
The message for any practice is that the website is part of the clinical pathway, not a brochure, a reflection of the system behind it, which at Blue Fin Vision® is consultant-led, transparent and accountable.
Presentation Two: Dr Bukie Hove
Converting Enquiries into Booked Consultations
Dr Bukie Hove takes up the pathway where the online consultation ends and the booking begins, and makes a deliberately unfashionable case: why Blue Fin Vision® charges for consultations, and why it works.
Dr Bukie Hove’s presentation on the economics of the front door.
Most practices give consultations away. Blue Fin Vision® does not, and the argument against “free” is that a free consultation is never actually free; it is paid for in non-attendance. Across the UK, missed hospital outpatient appointments are estimated to cost the NHS close to £1 billion a year;⁶ in high-volume, free-consultation settings the proportion who fail to attend is higher still. The hidden cost is doing the work to book twelve patients and seeing six, several of whom arrive holding a competitor’s quote, ready to reduce surgeon skill, lens technology and complication management to a single number.
A charged consultation changes that entirely. It is not a discount strategy; it is a filter. A patient who pays to be seen has already chosen the practice in principle: attendance improves, price stops dominating the room, and competitor brochures stay at home. The clinical conversation is freed to be exactly that.
The trade-off Dr Hove is candid about is that charging moves the contest upstream, to the enquiry itself. Every enquiry becomes a value conversation. Her principle resolves the tension cleanly: do not compete on price at the consultation; compete on value at the enquiry. Get the patient onto the phone, because conversation persuades where email only informs; lead with the surgeon, the outcomes and the lens before the fee; and frame the fee itself as a signal of seriousness, on both sides. Conviction is built before the booking, not after it.
Why Two Speakers, and Not One
The two presentations are complementary by design. Mr Hove’s documented transparency builds qualified demand and brings patients to the practice already informed and already inclined; Dr Hove’s enquiry process converts that demand into committed consultations rather than price negotiations. A demand engine, and a conversion system.
The reason both the founder and the practice manager sit on this faculty is that the result is not a charismatic surgeon but a system, repeatable, auditable, and not dependent on any single personality. Clinical leadership and operational leadership, represented together, is what allows a single independent clinic to behave like a scalable clinical organisation rather than a one-person practice. In practice that system is specific and unglamorous: a library of documented clinical answers, one diagnostic pathway every patient follows, outcomes audited against a national database, and a charged-enquiry process that determines who reaches the consulting room, none of it dependent on a single person being in the building. Most independent practices present as a good surgeon and a website; what is being discussed in Istanbul is closer to a clinical platform.
The wider panel shares the theme. Dr Wendelstein’s session on building a research-anchored clinician brand amplified by AI rests on the same foundation: the scarce asset is no longer content production but having something real to amplify, peer-reviewed research in his case, documented practice and published outcomes in Blue Fin Vision®’s. Across very different clinics, the conclusion converges. Authority cannot be bought; it can only be earned and then amplified.
UK Practice Innovation, Discussed at European Level
Istanbul is one of several international faculty engagements for Blue Fin Vision® in 2026, spanning the ZEISS programme, Shanghai, Istanbul and Lausanne, and the ESCRS Annual Congress in London, and marking a second consecutive year on the ZEISS EMEA faculty. The value of these meetings is not the platform but the pressure-testing: practice doctrine examined by peers who run very different clinics in very different markets.
The principles Blue Fin Vision® is taking to Istanbul are not theory. They are how the practice runs every day, for every patient, and they begin from a single observation that the rest of the field is still catching up to: the first consultation has already moved online. The practices that understand this are quietly building for it.
References
- Tan SS, Goonawardene N. Internet health information seeking and the patient-physician relationship: a systematic review. Journal of Medical Internet Research. 2017;19(1):e9.
- Hanauer DA, Zheng K, Singer DC, Gebremariam A, Davis MM. Public awareness, perception, and use of online physician rating sites. JAMA. 2014;311(7):734-735.
- Li X, Chou SY, Deily ME, Qian M. Comparing the impact of online ratings and report cards on patient choice of cardiac surgeon: large observational study. Journal of Medical Internet Research. 2021;23(10):e28098.
- Ahmed KJ, Pilling JD, Ahmed K, Buchan J. Effect of a patient-information video on the preoperative anxiety levels of cataract surgery patients. Journal of Cataract and Refractive Surgery. 2019;45(4):475-479.
- Day AC, Donachie PHJ, Sparrow JM, Johnston RL. The Royal College of Ophthalmologists’ National Ophthalmology Database study of cataract surgery: report 1, visual outcomes and complications. Eye (London). 2015;29(4):552-560.
- NHS England. Reducing did not attends (DNAs) in outpatient services. London: NHS England; 2023. Available from: https://www.england.nhs.uk/long-read/reducing-did-not-attends-dnas-in-outpatient-services/[england.nhs]
ABOUT THE AUTHOR
Mr Mfazo Hove
Consultant Ophthalmic Surgeon
MBChB MD FRCOphth CertLRS
Mr Mfazo Hove is a Consultant Ophthalmic Surgeon with experience spanning more than 57,000 procedures. He completed 6.5 years of specialist training at Moorfields Eye Hospital and served for five years as a consultant at the Western Eye Hospital, Imperial College Healthcare NHS Trust. He is the founder of Blue Fin Vision®, a consultant-led private ophthalmology practice operating across London, Essex, and Hertfordshire. His clinical expertise encompasses advanced cataract surgery, refractive lens replacement, laser vision correction, and implantable Collamer lenses (ICL).
A ZEISS Key Opinion Leader, Mr Hove is a respected international speaker with five invited engagements across seven cities in 2026:
- ZEISS China tour (Changsha, Shanghai, and Hangzhou, April – ZEISS APAC User Meeting)
- RCOphth Annual Congress – May – Manchester
- ZEISS EMEA User Meeting (Istanbul)
- ZEISS Lausanne User Meeting (Lausanne)
- European Society of Cataract and Refractive Surgeons Annual Congress (ESCRS, London)
Schedule Your Consultation Today
To discuss your options with a consultant-led UK clinic with documented outcomes and multiple locations across London, Hertfordshire and Essex, book a consultation with the Blue Fin Vision® team.
